Exelixis, Inc.
EXEL
$49.46
-$0.25-0.50%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.38B | 2.32B | 2.29B | 2.23B | 2.30B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.38B | 2.32B | 2.29B | 2.23B | 2.30B |
| Cost of Revenue | 84.48M | 83.70M | 77.18M | 75.94M | 74.13M |
| Gross Profit | 2.29B | 2.24B | 2.21B | 2.15B | 2.22B |
| SG&A Expenses | 521.15M | 518.73M | 530.03M | 518.17M | 515.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.42B | 1.43B | 1.47B | 1.48B | 1.48B |
| Operating Income | 957.18M | 892.70M | 820.25M | 751.74M | 814.51M |
| Income Before Tax | 1.00B | 941.21M | 873.29M | 775.63M | 838.06M |
| Income Tax Expenses | 169.78M | 158.64M | 195.39M | 173.34M | 194.50M |
| Earnings from Continuing Operations | 833.42 | 782.57 | 677.90 | 602.30 | 643.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 833.42M | 782.57M | 677.90M | 602.30M | 643.57M |
| EBIT | 957.18M | 892.70M | 820.25M | 751.74M | 814.51M |
| EBITDA | 985.84M | 921.76M | 850.00M | 781.52M | 844.28M |
| EPS Basic | 3.13 | 2.89 | 2.46 | 2.16 | 2.26 |
| Normalized Basic EPS | 2.40 | 2.22 | 2.03 | 1.85 | 1.95 |
| EPS Diluted | 3.01 | 2.77 | 2.37 | 2.08 | 2.20 |
| Normalized Diluted EPS | 2.32 | 2.14 | 1.96 | 1.79 | 1.91 |
| Average Basic Shares Outstanding | 1.07B | 1.09B | 1.10B | 1.12B | 1.14B |
| Average Diluted Shares Outstanding | 1.11B | 1.13B | 1.14B | 1.16B | 1.17B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |